Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NLST watch what happens to google,micron and Samsung:)$$$
Gold Bullion Prices up today on Demand
Precious Metals EXPLODE Today on Geopolitics Safe Haven
$SGTM huge premarket news: The Sustainable Green Team, LTD. Enters into a Purchase Agreement to Increase HumiSoil® Production with an Additional 4 Million Cubic Yards https://www.globenewswire.com/news-release/2023/05/24/2675218/0/en/The-Sustainable-Green-Team-LTD-Enters-into-a-Purchase-Agreement-to-Increase-HumiSoil-Production-with-an-Additional-4-Million-Cubic-Yards.html
$OCLN News!! OriginClear’s Subsidiary Water On Demand Signs MOU Regarding Acquisition of Established SaaS Developer
https://finance.yahoo.com/news/originclear-subsidiary-water-demand-signs-203000022.html
$SGTM News is out!! The Sustainable Green Team, LTD. Enters into a Purchase Agreement to Increase HumiSoil® Production with an Additional 4 Million Cubic Yards
https://finance.yahoo.com/news/sustainable-green-team-ltd-enters-122500659.html
Good morning
$HMBL “The capitalization of the company is critical, along with a comprehensive restructuring of debt and share classes, as well as reducing dilution in an effort to drive value for shareholders and prepare the company for uplisting to a major exchange.”
https://www.barrons.com/articles/humbl-receives-funding-commitment-of-up-to-21-million-as-an-initial-step-in-a-comprehensive-plan-to-recapitalize-the-company-and-pursue-uplisting-to-a-major-exchange-cda48186?mod=md_stockoverview_news #technology #sales #ceo
$SOBR
$SOBR This video shows just how important this company has become in keeping the public safe.. pic.twitter.com/rmUoySjmgx
— Tommy Boy Trader (@QuabbinR) May 24, 2023
$HMBL Another funding strategy the company intends to employ is to file an offering under Regulation A+. Regulation A+ allows companies to raise money under two different tiers. Fully reporting SEC reporting companies such as HUMBL are able to raise up to $75,000,000 on a Tier 2 offering in any 12-month period from the general public. The company hopes to attract a new shareholder base that uses the HUMBL technology and would like to help fund the company directly.
The company will continue in its efforts to secure additional funding and reduce debt in preparation for its attempts to uplist to a major exchange in the future.
$SGTM The Sustainable Green Team, LTD. Receives a $46.8 Million HumiSoil® Purchase Order from the Middle East and Africa
https://finance.yahoo.com/news/sustainable-green-team-ltd-receives-123000613.html
$HMBL is doing the first concert that has NFT tickets in the Oceania region.
$HMBL was the first digita walet partner of a fine four NCAA basketball program.
RESHAPE LIFESCIENCES (RSLS) : 2.70
52w: 2.21 – 52,5
Shares Outstanding : 2.94M
Float : 2.54M
Book Value Per Share (mrq) 7.05
Cash and Cash Equivalents as of March 31, 2023, were $9.1 million and the company remains debt free on its balance sheet
“In 2023, we have continued to leverage operational efficiencies, optimize our lead generation programs, and invest in our growth drivers. Our achievement of a 42.9% reduction in operating expenses, excluding one-time charges, during the first quarter, as compared to the same period last year, is a direct result of the execution of our growth pillars. We will continue to drive revenue by expanding our product offering to treat obesity and metabolic disease across the entire care continuum and strengthen our position to exceed our goals,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences®. “We remain focused, not only on growth, but also our future profitability and delivering predictable shareholder value. Our balance sheet was bolstered by two capital raises this year, totaling $12.7 million in gross proceeds. These funds will allow us the continued ability to generate awareness of our evidence-based and differentiated product portfolio that spans the entire care continuum.”
MATTHEW NACHTRAB REPORTS 27.7% STAKE IN RESHAPE LIFESCIENCES AS
NACHTRAB-PURCHASED CO'S COMMON STOCK BASED ON BELIEF THAT SUCH SECURITIES, AT CURRENT MARKET PRICES, REPRESENTED AN ATTRACTIVE INVESTMENT OPPORTUNITY
NACHTRAB - WROTE A LETTER TO THE CEO OF CO WITH RECOMMENDATIONS FOR THE MANAGEMENT TEAM’S STRATEGY GOING FORWARD
I am excited for your new tenure as CEO of ReShape Lifesciences and I believe your team can rebuild and create a $100m plus market cap company with some austerity measures, leveraging assets currently owned, and capitalizing on the medicated weight loss secular trend to generate lead flow and massive revenue growth. I am willing to discuss this and advise in any way I can help.
Time for a strong rebound:
Feb 03, 2023 13.1400 22.4000 11.5600 17.0400 17.0400 11,599,000
Jan 03, 2023 9.6600 20.6300 9.4500 15.6600 15.6600 12,363,900
AZERION GROUP : 1.52
NL00150006Z9
52w: 1.28 – 9.20
Revenue went from 308 (2021) to 423 (2022)
Latest news:
https://www.azerion.com/azerion-claims-second-spot-as-frances-premier-exclusive-advertising-network/
https://www.azerion.com/azerions-q1-2023-wrap-up/
Azerion Group BV, formerly known as European FinTech IPO Co 1 BV, is a software publishing company based in the Netherlands. The Company is principally engaged in delivering digital entertainment and media platform for media buyers and sellers. The Company operates through Platform and Premium Games segments. Platform segment includes casual games distribution, advertising and e-commerce, which are integrated through its technology. Platform is also integrated with its Premium Games segment. Premium Games include nine game titles of card games and metaverse. Azerion Holding B.V. is the Company’s main operational holding subsidiary. The Company owns several subsidiaries in Germany and France, among others.
lets hope we get some goodies nice close
XCRT - .0535 HOD and great close. Interview tomorrow should have some incredible updates and there should be substantial news to follow imo!
$CNNA There has been a significant merger and a new acquisition. The stock has been suppressed due to the financial information not being currently up to date. However, there is great news as Cann American Corp's operations and financial information are now officially listed as "CURRENT" with the Secretary of State of Wyoming. As a result, we can expect the filing of these reports with the SEC at any time.
BIOC might bounce back green here
MCLD.......SVRA.......BFLY........BLND.......KPTI......NINE......https://stockcharts.com/h-sc/ui?s=NINE
https://stockcharts.com/h-sc/ui?s=KPTI
https://stockcharts.com/h-sc/ui?s=BLND
https://stockcharts.com/h-sc/ui?s=BFLY
https://stockcharts.com/h-sc/ui?s=SVRA
https://stockcharts.com/h-sc/ui?s=MCLD
KOAN news May 23, 2023 - 9:25 am
The Company Signs a Non-Binding Letter of Intent for a Transformational Transaction
CALABASAS, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- Resonate Blends, Inc. (OTCQB: KOAN) (“Resonate Blends” or the “Company”) is pleased to report it has entered into a non-binding letter of intent (“LOI”) to complete an acquisition of Pegasus Specialty Vehicles, LLC (“Pegasus”). A Letter to Shareholders from Resonate’s Chairman and CEO Geoff Selzer follows:
Dear Shareholders,
When Resonate Blends first entered the public sector in late 2019, we made clear our mission was to provide shareholder value for the investors who believed in our commitment of demystifying cannabis to the emerging wellness market and creating innovative products designed to support intentional and mindful use as a core part of daily wellness. We believed we accomplished this goal with the creation of our award-winning Koan Cordials.
Since late 2019, we have been attempting to raise money to implement our business plan, including our planned acquisition strategy, but have not been able to secure all the funds necessary to do so for several reasons. The present economy without federal cannabis reform, the restrictions on commercial banking, the saturated nature of the cannabis industry, the strength of the illicit market and the decline in public investor interest in cannabis stocks over the past 18 months have all prevented this from happening. We have been very vocal in our belief that all stakeholders, from our employees, our customers and our financial community, need to be considered as we drive our strategy. We are clear that a relative startup in the cannabis industry, as a public company, does not serve those interests and have decided to set our sights on new opportunities.
We have recently commenced a search for other businesses that may benefit our existing shareholders and bring in new investors and opportunities. As a result, we were recently approached with a new opportunity for the public company that we feel may bring improved commercial and shareholder value. We’ve been told by many that Resonate is attractive to private companies due to our capital structure, fully-reporting SEC status and our loyal investor base. We have worked hard over the years to maintain a healthy capital structure attractive to private companies looking to become public.
After completion of our due diligence, we signed a non-binding letter of intent (LOI) with Pegasus Specialty Vehicles, LLC (“Pegasus”) on April 21, 2023. This opportunity in the rapidly growing clean energy sector presents a unique opportunity for our shareholders and is consistent with our perspective of value-based investing. Pegasus is an innovative leader in the low-emission and zero-emission electric vehicle (“EV”) and emerging hydrogen fuel cell technology for school buses and specialty vehicles. The leadership team from Pegasus is well known and respected throughout the industry and their relationships have created a nationwide network of distributors to sell their buses and specialty vehicles in all 50 U.S. states, Canada, Micronesia, Guam, the U.S. Virgin Islands and the Caribbean.
The Pegasus advantage is in its flexible business model of addressing the needs of the traditional, hybrid electric, full electric (EV) battery and hydrogen fuel cell markets. To leverage their position in this emerging market, Pegasus has developed strategic partnerships with leaders in the EV and hydrogen fuel cell sectors, such as Peterbilt, Zeus Electric Chassis, Hyperion Motors and Via Motors. There is a lot more to know about Pegasus and its future growth plans, but we will save this information for an expected later announcement.
To summarize, we are excited to let the investment community and our loyal shareholders know we are moving our public holding company towards an opportunity we all feel will provide a clearer path to near term revenue opportunities, revenue growth and overall profitability than what our current business can provide.
As always, we are grateful for our shareholders’ support and patience as we continue the process towards our expected closing of Pegasus. We expect to be in contact over the coming weeks detailing our progress towards this exciting opportunity.
In the meantime, stay safe, stay healthy.
Geoff Selzer
CEO
Completion of the Proposed Merger is subject to the negotiation of a definitive merger agreement and related documentation, approval of the Proposed Merger by our Board of Directors, the completion of due diligence to the satisfaction of both parties, financing and satisfaction of other conditions that are to be negotiated as part of the merger agreement. Accordingly, there can be no assurance that a merger agreement will be entered into or that the Proposed Merger will be consummated.
$BGSM Strong trading day here..and love the uptick in volume..continues on watch here..
$SOBR Continues to improve their already stellar product..price should soon follow..
NAFS
Havana Roasters Coffee is not only a cuban gourmet coffee brand it's an experience with every taste you can't forget! https://t.co/cIfFsMB0l4 pic.twitter.com/5kr7zEOsyx
— North America Frac Sand, Inc. dba HRC Company (@HRCcoffee) May 23, 2023
BMXI
Management have just arranged an updated video of our Talawaan property with a better perspective of the overall size of our resource area and infrastructure… check the video and follow us for updates! $BMXI https://t.co/hk69hA1uGe
— Brookmount Gold (@brookmountgold) May 23, 2023
CNNA
We expect one of several upcoming $CNNA updates to release tomorrow.
— CNNA (@CNNA_OTC) May 23, 2023
1 dollar today??
NVFY: 0,7388 + 53.92%
Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living, dining, and bedrooms, as well as home offices. Its products include sofas, chairs, dining and coffee tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinic, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.
https://novalifestyle.com/
Feb 01, 2023 0.9300 1.3700 0.6700 0.7500 0.7500 1,080,000
Jul 31, 2022 0.7400 1.3400 0.7000 0.7500 0.7500 6,661,300
Mar 01, 2021 3.0100 7.4900 2.0400 3.2400 3.2400 45,086,500
NOVA LIFESTYLE INC (NVFY) 0,5616 +17,00%
Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living, dining, and bedrooms, as well as home offices. Its products include sofas, chairs, dining and coffee tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinic, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.
https://novalifestyle.com/
Shares Outstanding 6.95M
Float 4.17M
Book Value Per Share (mrq) 0.75
May 01, 2023 0.5400 0.6100 0.4800 0.4800 0.4800 76,700
Apr 01, 2023 0.6100 0.7200 0.5500 0.5500 0.5500 145,500
Mar 01, 2023 0.6700 0.7600 0.5100 0.6000 0.6000 134,600
Feb 01, 2023 0.9300 1.3700 0.6700 0.7500 0.7500 1,080,000
Jan 01, 2023 0.4600 0.9000 0.4400 0.8500 0.8500 472,700
Dec 01, 2022 0.5300 0.5900 0.3900 0.4300 0.4300 423,200
Oct 31, 2022 0.6100 0.6800 0.4700 0.5100 0.5100 303,100
Sep 30, 2022 0.7200 0.8100 0.5900 0.6000 0.6000 286,200
Aug 31, 2022 0.7600 0.8100 0.6800 0.7400 0.7400 474,900
Jul 31, 2022 0.7400 1.3400 0.7000 0.7500 0.7500 6,661,300
Jun 30, 2022 0.7600 0.8100 0.6800 0.7400 0.7400 252,900
May 31, 2022 0.7800 1.0300 0.6300 0.7200 0.7200 1,298,900
Apr 30, 2022 1.0700 1.1800 0.6300 0.7800 0.7800 625,200
Mar 31, 2022 1.5000 1.7900 1.0300 1.0600 1.0600 834,400
Mar 01, 2022 1.2900 1.5600 1.1400 1.5000 1.5000 1,246,800
Feb 01, 2022 1.5500 1.7900 1.2500 1.3200 1.3200 1,674,100
Jan 01, 2022 1.8600 1.9900 1.4700 1.6000 1.6000 1,167,400
Dec 01, 2021 1.9800 2.0800 1.7700 1.8700 1.8700 1,115,600
Oct 31, 2021 2.2800 2.4800 1.8700 1.9500 1.9500 1,774,900
Sep 30, 2021 2.2800 2.7100 2.1000 2.2700 2.2700 4,279,100
Aug 31, 2021 2.3300 2.4600 2.0800 2.2700 2.2700 3,544,800
Jul 31, 2021 2.2800 2.6000 1.9000 2.3700 2.3700 5,851,200
Jun 30, 2021 3.1400 6.6600 2.1000 2.2800 2.2800 56,231,500
May 31, 2021 3.0000 3.4100 2.7700 3.1400 3.1400 899,200
Apr 30, 2021 2.8100 3.5900 2.5200 2.9900 2.9900 1,329,900
Mar 31, 2021 3.3500 3.4400 2.6100 2.7300 2.7300 734,000
Mar 01, 2021 3.0100 7.4900 2.0400 3.2400 3.2400 45,086,500
$HMBL HUMBL Selected as Official Digital Wallet and Ticketing Technology Provider for “Motherland Samoa 2023” Festival
https://finance.yahoo.com/news/humbl-selected-official-digital-wallet-185500287.html
XCRT interview with CEO tomorrow Wednesday May 24th 1 Pm EST
https://twitter.com/i/spaces/1ZkJzXAQqeaKv
FLCX http://archive.fast-edgar.com/20230523/AOZCVQ2CZ22FHZM3222V2ZZ2NVSNZZ28Z252/ CEO continues to add at these levels dont know what more peeps want to see but I'm holding for PRs/8Ks and $10 PPS breakout for starters
XCRT broke 05 heading for the 07 52 week high, PR coming and CEO interview tomorrow, more details coming
Exciting news for $XCRT!
— Xcelerate, Inc. (@XcelerateUS) May 19, 2023
Here's what's coming next week:
1️⃣ Big announcements & potential PR on the way!
2️⃣ We have a follow-up interview with Tiger Stock Discord (@cooltigerx & @Punk_Stocks ) scheduled for Wednesday, May 24th
$HMBL The commercial division has the first government approved wallet in the U.S.
$HMBL Pursuant to the Convertible Promissory Note issued to Pacific Lion by HUMBL, Pacific Lion has the right to fund up to $800,000. The note bears interest at 6% and is due on May 10, 2024. Following an uplisting to a senior stock exchange, the note will automatically convert at 80% of the uplisting offering price. In addition to the note, the Company also issued a Warrant to Purchase Shares of Common Stock to Pacific Lion. The warrant is exercisable for 500,000 shares for a period of five years at $0.10 per share. In the event that an uplisting to a senior stock exchange does not occur within nine months of the issuance date, the warrant will automatically be canceled. The note is designed to provide a mechanism for Pacific Lion to make regular fundings to cover HUMBL’s working capital needs during the pendency of the registration statement. Pacific Lion funded the first tranche of $100,000 upon the issuance of the note.
https://www.marketwatch.com/press-release/humbl-receives-funding-commitment-of-up-to-21-million-as-an-initial-step-in-a-comprehensive-plan-to-recapitalize-the-company-and-pursue-uplisting-to-a-major-exchange-2023-05-15?mod=mw_quote_news_seemore
$THER .0028 ^55% Definitive Merger Agreement
All Content and Data provided by Third-Parties — Terms of Use
Theralink® Signs Definitive Merger Agreement to be Acquired by IMAC Holdings, a Nasdaq Listed Company
PR NEWSWIRE 8:30 AM ET 5/23/2023
Symbol Last Price Change
THER 0.0027down +0.0009 (+50%)
BACK 0.1632up +0.0214 (+15.0917%)
QUOTES AS OF 10:57:42 AM ET 05/23/2023
Theralink's (THER) patented technology is helping to solve a significant problem in cancer treatment by providing game changing technology that can predict which FDA-approved drugs may be effective in each solid tumor cancer
GOLDEN, Colo. , May 23, 2023 /PRNewswire/ -- Theralink Technologies, Inc.(THER) (OTC: THER) ("Theralink(THER)") and IMAC Holdings, Inc.(BACK) ("IMAC(BACK)"), today announced that they have entered into a definitive Agreement and Plan of Merger (the "Merger Agreement") under which Theralink(THER) will merge with a newly-formed wholly-owned subsidiary of IMAC(BACK) in a stock-for-stock reverse merger transaction (the "Merger") in which Theralink(THER) will survive as a wholly-owned subsidiary of IMAC(BACK), a Nasdaq-listed company. If completed, the Merger will result in a combined company that will focus on end-to-end proteomics testing, one of the most robust and growing areas of medicine.
The Theralink® Test for Advanced Breast Cancer measures the abundance and activation of 32 clinically actionable biomarkers. The test reports which of the 32 biomarkers are highly expressed or activated and the FDA-approved therapeutics that target them. This test is a novel tool that broadens actionability and supports oncologists in selecting the most effective treatment plan for their cancer patients.
Recently, Theralink(THER) received a Medicare reimbursement rate determination as well as added to its evidence based clinical utility data via an observational registry study that demonstrated greater than 90% actionability and greater than 70% clinical utility for the test. The Theralink(THER) test may be deemed necessary to achieve a personalized and targeted approach to breast cancer treatment
Through its current and planned lab developed tests (LDTs), Theralink's(THER) technology hopes to target multiple areas of oncology and drug development. In addition to the Company's first test for advanced breast cancer, Theralink(THER) is actively working on a pan-tumor test for solid tumors across multiple tumor types such as ovarian, endometrial, head and neck, pancreatic, colorectal, lung, prostate, among others.
Dr. Mick Ruxin, CEO of Theralink(THER) summed up the transaction by saying, "Our team is motivated by the enormous impact we can have on cancer care by making our test more accessible to all cancer patients. We are excited to be making that a reality by embarking on our next chapter with this merger with IMAC(BACK)." He went on to say, "It is anticipated that the potential merger and listing will allow the Company broader access to capital, which will be invested in our business to accelerate market access and reimbursement initiatives for our clinical patient testing, expand our product offering portfolio and research initiatives, and increase our laboratory throughput." Dr. Ruxin further said, "With our predictive, protein biomarker test, oncologists may have better insights into each individual cancer patient's unique biology and to the targeted therapies that act upon each patient's unique cancer."
About the Transaction
The Merger is structured as a stock for stock reverse merger whereby all of Theralink's(THER) outstanding equity interests are to be exchanged for shares of IMAC(BACK) common stock. Theralink(THER) stakeholders are expected to own approximately 85% of the combined company, and pre-merger IMAC(BACK) equity holders are expected to own approximately 15% of the combined company, on a fully diluted basis calculated using the treasury stock method, subject to certain adjustments provided for in the Merger Agreement. The boards of directors of both companies have unanimously approved the Merger Agreement. The merger is expected to close late in the third quarter or early in the fourth quarter of 2023, subject to satisfying certain closing conditions, including the completion of satisfactory due diligence by both parties and the receipt of shareholder approval by both companies. All current IMAC(BACK) directors but one will resign effective upon the closing of the Merger, and the existing directors of Theralink(THER) shall be appointed to the board of IMAC(BACK), with Jeffrey Busch to serve as Chairman.
Advisors
Joseph Gunnar & Co., LLC is serving as the exclusive financial advisor to IMACHoldings, Inc. and Theralink Technologies, Inc. in connection with the Transaction. Olshan Frome Wolosky LLP is serving as legal counsel for IMACHoldings, Inc. and K&L Gates is serving as legal counsel for Theralink Technologies, Inc.
About Theralink Technologies, Inc.(THER)
Theralink Technologies (THER) is a proteomics-based, precision medicine company with a nationally CLIA-certified and CAP-accredited laboratory located in Golden, Colorado. Through its unique and patented phosphoprotein and protein biomarker platform and LDTs, Theralink's(THER) technology targets multiple areas of oncology and drug development. In addition to the Company's first assay for advanced breast cancer, Theralink(THER) is actively working on a second assay that is planned to be pan-tumor for solid tumors across multiple tumor types such as ovarian, endometrial, pancreatic, liver, head and neck, colorectal, lung, prostate, among others. Theralink(THER) provides precision oncology data through its powerful Theralink® Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. Theralink(THER) intends to help improve cancer outcomes for patients, help reveal therapeutic options for oncologists, and support biopharmaceutical drug development by using a beyond-genomics approach to molecular profiling that directly measures drug target levels and activity. For more information, please visit www.theralink.com.
About IMAC Holdings, Inc.(BACK)
IMAC Holdings owns and manages health and wellness centers that deliver sports medicine, orthopedic care, and restorative joint and tissue therapies for movement restricting pain and neurodegenerative diseases. IMAC is comprised of two business segments: outpatient medical centers and a clinical research division. With treatments to address both young and aging populations, IMAC Holdings owns or manages outpatient medical clinics that deliver regenerative rehabilitation services as a minimally invasive approach to acute and chronic musculoskeletal and neurological health problems. IMAC's(BACK) research division is currently conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. For more information visit www.imacholding.com.
Important Additional Information and Where to Find It
In connection with the proposed Merger between IMAC(BACK) and Theralink(THER), IMAC(BACK) intends to file with the Securities and Exchange Commission (the "SEC") a registration statement on Form S-4 (the "Registration Statement") to register the shares of IMAC's(BACK) common stock to be issued in connection with the proposed Merger. The Registration Statement will include a document that serves as a prospectus of IMAC(BACK) and joint proxy/information statement of IMAC(BACK) and Theralink(THER) (the "joint proxy statement/prospectus"), and each party will file other documents regarding the proposed Merger with the SEC. INVESTORS AND SECURITYHOLDERS OF IMAC AND THERALINK ARE URGED TO CAREFULLY AND THOROUGHLY READ, WHEN THEY BECOME AVAILABLE, THE REGISTRATION STATEMENT, THE JOINT PROXY STATEMENT/PROSPECTUS, AS EACH MAY BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME, AND OTHER RELEVANT DOCUMENTS FILED BY IMAC AND THERALINK WITH THE SEC BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT IMAC, THERALINK AND THE PROPOSED MERGER, THE RISKS RELATED THERETO AND RELATED MATTERS.
After the Registration Statement has been declared effective, a definitive joint proxy statement/prospectus will be mailed to shareholders of IMAC(BACK) and of Theralink(THER). Investors will be able to obtain free copies of the Registration Statement and the joint proxy statement/prospectus, as each may be amended from time to time, and other relevant documents filed by IMAC(BACK) and Theralink(THER) with the SEC (when they become available) through the website maintained by the SEC at www.sec.gov. Copies of documents filed with the SEC by IMAC(BACK), including the joint proxy statement/prospectus (when available), will be available free of charge from IMAC's(BACK) website at www.ir.imacregeneration.com. Copies of documents filed with the SEC by Theralink(THER), including the joint proxy statement/prospectus (when available), will be available free of charge from Theralink's(THER) website at www.theralink.com under the "Investor Relations" tab.
Participants in the Solicitation
IMAC (BACK) , Theralink (THER) and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of IMAC (BACK) in connection with the proposed transaction. Information about IMAC's (BACK) directors and executive officers is set forth in IMAC's (BACK) Annual Report on Form 10-K for the year ended December 31, 2022 which was filed with the SEC on March 31, 2023, as amended, its definitive proxy statement for the 2023 annual meeting of stockholders filed with the SEC on May 11, 2023 and the joint proxy statement/prospectus (when available). Information about Theralink's (THER) directors and executive officers is set forth in Theralink's (THER) Annual Report on Form 10-K for the year ended September 30, 2022 which was filed with the SEC on December 29, 2022, and the joint proxy statement/prospectus (when available). Other information regarding the interests of such individuals, as well as information regarding other persons who may be deemed participants in the proposed transaction, will be set forth in the Registration Statement, the joint proxy statement/prospectus and other relevant materials to be filed with the SEC when they become available. Shareholders of IMAC (BACK) and Theralink (THER) , potential investors and other readers should read the joint proxy statement/prospectus carefully when it becomes available before making any voting or investment decisions.
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Cautionary Note Regarding Forward-Looking Statements
This communication contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, included in this communication that address activities, events or developments that IMAC (BACK) or Theralink (THER) expects, believes or anticipates will or may occur in the future are forward-looking statements. Words such as "estimate," "project," "predict," "believe," "expect," "anticipate," "potential," "create," "intend," "could," "would," "may," "plan," "will," "guidance," "look," "goal," "future," "build," "focus," "continue," "strive," "allow" or the negative of such terms or other variations thereof and words and terms of similar substance used in connection with any discussion of future plans, actions, or events identify forward-looking statements. However, the absence of these words does not mean that the statements are not forward-looking. These forward-looking statements include, but are not limited to, statements regarding the proposed Merger, the expected closing of the proposed Merger and the timing thereof and as adjusted descriptions of the post-transaction company and its operations, strategies and plans, integration, debt levels and leverage ratio, capital expenditures, cash flows and anticipated uses thereof, synergies, opportunities and anticipated future performance, including maintaining current Theralink (THER) management. Information adjusted for the proposed Merger should not be considered a forecast of future results. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements included in this communication. These include the risk that cost savings, synergies and growth from the proposed Merger may not be fully realized or may take longer to realize than expected; the possibility that shareholders of IMAC (BACK) may not approve the issuance of new shares of IMAC (BACK) common stock in the proposed Merger or that shareholders of IMAC (BACK) may not approve the proposed Merger; the risk that a condition to closing of the proposed Merger may not be satisfied, that either party may terminate the Merger Agreement or that the closing of the proposed Merger might be delayed or not occur at all; potential adverse reactions or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed Merger; the occurrence of any other event, change or other circumstances that could give rise to the termination of the Merger Agreement relating to the proposed Merger; the risk that changes in IMAC's (BACK) capital structure and governance could have adverse effects on the market value of its securities and its ability to access the capital markets; the ability of IMAC (BACK) to retain its Nasdaq listing; the ability of Theralink(THER) to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on Theralink's(THER) operating results and business generally; the risk the proposed Merger could distract management from ongoing business operations or cause IMAC(BACK) and/or Theralink(THER) to incur substantial costs; the risk that Theralink(THER) may be unable to reduce expenses; the impact of the COVID-19 pandemic, any related economic downturn; the risk of changes in regulations effecting the healthcare industry; and other important factors that could cause actual results to differ materially from those projected. All such factors are difficult to predict and are beyond IMAC's(BACK) or Theralink's(THER) control, including those detailed in IMAC's(BACK) Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that are available on IMAC's(BACK) website at www.ir.imacregeneration.com and on the website of the Securities and Exchange Commission (the "SEC") at www.sec.gov, and those detailed in Theralink's(THER) Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K that are available on Theralink's(THER) website at www.theralink.com and on the website of the SEC. All forward-looking statements are based on assumptions that IMAC(BACK) and Theralink(THER) believe to be reasonable but that may not prove to be accurate. Any forward-looking statement speaks only as of the date on which such statement is made, and neither IMAC(BACK) nor Theralink(THER) undertakes any obligation to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable law. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.
Cision View original content:https://www.prnewswire.com/news-releases/theralink-signs-definitive-merger-agreement-to-be-acquired-by-imac-holdings-a-nasdaq-listed-company-301832039.html
SOURCE Theralink Technologies(THER)
"ROFL BS POST DUDE- A JUDGE CALLED THE BS OUT AND RULED IN FAVOR OF $DBMM SO THAT BS ACTION WAS NUL AND VOID AHAHAHAHAHAHA
"
Yes DBMM
Any undiscovered #AI pennystock (and I mean "pennystock") out there?
DBMM just hit Penny!!!!!!!now watch for the Nickel run up TODAY!!!!! LIKE Clockwork!!
Followers
|
8275
|
Posters
|
|
Posts (Today)
|
92
|
Posts (Total)
|
2342142
|
Created
|
12/20/05
|
Type
|
Free
|
Moderator MOMO | |||
Assistants i_like_bb_stock Cube balamidas |
*** PURPOSE of the BOARD is to alert both penny and big board stocks which are breaking out in play.
Furthermore, this board provides an open forum for both experienced and new traders alike to shares their stock picks, opinions and experiences.
At one time or another, we were all new to trading and looking for a place to learn and understand the market, which is one of the main reasons this board was created.
This forum provides new investors a place to learn and feel comfortable doing it.
*** ALERTS are based on stocks that show an acceleration of price or volume; showing signs of reversing based on their chart and volume are not suitable for all investors.
Due to the increased volatility and high risk exposure when trading penny stocks, it is possible to lose your entire investment.
Taking profits, due diligence and preservation of your initial investment is key and must be taken into consideration.
All stocks mentioned are welcome herr and range from pennies to the big boards and everything in between.
Do your own due diligence before investing and never trade more than you can afford to lose.
Traders should plan their exits before they trade and take profits the way up.
We are here to help -- let us know if we can be of any assistance.
*** A MUST HAVE for TRADERS http://www.equityfeed.com/
IMPORTANT / USEFUL LINKS
SHO LIST: http://www.nasdaqtrader.com/aspx/regsho.aspx
BUYINS.NET: http://www.buyins.net/
POST S-8 PLAYS: http://www.investorshub.com/boards/board.asp?board_id=1605
TOXIC FILINGS: http://www.investorshub.com/boards/board.asp?board_id=4318
REVERSE SPLITS: http://www.investorshub.com/boards/board.asp?board_id=3017
DEATH DROP: http://www.investorshub.com/boards/board.asp?board_id=3341
PRESS RELEASES:http://home.businesswire.com/portal/site/home/index.jsp?front_door=true
1512g Filings - http://1512g.com/
American Stock Exchange - http://www.nyse.com/attachment/amex_landing.htm
Authorized Shares for Nevada and Other States - http://www.authorized-shares.com/
Barrons - http://online.barrons.com/public/main
BioHealth - http://www.biohealthinvestor.com/
BioMed - http://biomedreports.com/
BioSpace - http://www.biospace.com/
Bloomberg - http://www.bloomberg.com
Business News - http://www.bloomberg.com
Business News - http://www.reuters.com/finance/markets
Business News Portal - http://www.businesswire.com/portal/site/home/
BusinessWeek - http://www.businessweek.com/
Candlesticks - www.candlesticker.com/Default.asp
Chart Analysis - www.stockcharts.com/school/doku.php
Chart Video Lessons - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46647251
Charts - http://bigcharts.marketwatch.com/avatar.asp
Charts - http://chartpatterns.com/
Charts - http://stockcharts.com/
Charts - http://www.incrediblecharts.com/technical/candlesticks.htm
China Business News - http://www.chinadaily.com.cn/bizchina/index.html
China Business News - http://www.xinhuanet.com/english2010/business/index.htm
China Technology News - http://www.chinatechnews.com/
Clinical Trials - http://www.clinicaltrials.gov/
CNBC - http://www.cnbc.com
CNNMoney.com - http://www.money.cnn.com/
Corporate Bankruptcy - http://www.sec.gov/investor/pubs/bankrupt.htm
Corporate Records Search - http://www.coordinatedlegal.com/SecretaryOfState.html
Corporate Records Search - http://www.searchsystems.net/list.php?nid=398
CUSIP number - http://activequote.fidelity.com/mmnet/SymLookup.phtml
DD Amanda - http://ddamanda.com/Members/AmandaChartStart.php
DD Machine - http://www.ddmachine.com/
Deregistering - http://www.aaii.com/commentary/articles/200601_stockstrategies.cfm
Dividends - http://www.dividenddetective.com/
Document Research - http://www.10kwizard.com/main.php
Earnings - http://www.earningswhispers.com/calendar.asp
Education - http://www.investopedia.com/?viewed=1
Email Address Verifier - http://verify-email.org/
EYE ON THE FDA - http://www.eyeonfda.com/
FINRA Daily Short List - www.regsho.finra.org/regsho-Index.html
Floats - http://investorshub.advfn.com/boards/board.aspx?board_id=15223
Fool.com - http://www.fool.com
Forbes - http://www.forbes.com/home_usa
Form 4 Filings - http://www.secform4.com/index.php
Google News Business - http://news.google.com/?ned=us&topic=b
Google News Home - http://news.google.com/
Holiday Schedule for Stock Markets - http://www.allstocks.com/html/stock_markets_holidays.html
High Short Interest Stocks - http://www.highshortinterest.com/
Insider Buy & Sell Info - http://www.insidercow.com/latestFillings/buyByCompany
Investing Glossary - http://www.investorwords.com/
Investopedia - http://www.investopedia.com/?viewed=1
Investors Business Daily - http://www.investors.com
Investor Words - http://www.investorwords.com/
Knobias - http://www.knobias.com/individual/public/quote.htm
Level 2 Video Tutorial - http://stockhideout.com/images/flash/level.html
Low Float Stocks - http://www.lowfloat.com/
MarketWatch.com - http://www.marketwatch.com/
Message, Blog & Twitter Postings - http://www.thelion.com
MicrocapMarkets NASDAQ <$5 - http://www.microcapmarkets.com/data_main_nav.jsp?market=NASDAQ
MicrocapMarkets OTCBB - http://www.microcapmarkets.com/data_main_nav.jsp?market=OTCBB
Mining - http://www.miningmx.com/
MSN Money Central - http://www.moneycentral.msn.com/investor/home.asp
Multicollinearity - www.stockcharts.com/help/doku.php
Mutual Fund Facts About Individual Stocks - http://www.mffais.com/
Naked Shorting - www.businessjive.com/
NASDAQ Stock Market - http://www.nasdaq.com/
NASDAQ/NYSE/AMEX Stock Info - www.secfilings.com/
Natural Resources News & Commentary - http://www.resourceinvestor.com/Pages/default.aspx
New York Stock Exchange - http://www.nyse.com/home.html
OTCBB Daily List - http://www.otcbb.com/dailylist/
Patterns - http://thepatternsite.com/
Pinksheets Stock Info - www.otcmarkets.com/pink/index.jsp
Platform - http://www.quotetracker.com/
Precious Metals - http://www.kitco.com/
Press Releases - http://www.prnewswire.com/news-releases/
REG SHO List - www.regsho.com/tools/short_list.php
Regional Bank List - http://www.bullsector.com/regionalbanks.html
Reverse Phone & Address - http://www.whitepages.com/reverse-lookup
Reverse Mergers - http://www.gopublic.com/reversemerger.html
Reverse Merger Report - http://reversemerger.dealflowmedia.com
Reverse Splits - http://investorshub.advfn.com/boards/board.aspx?board_id=3017
Screener - http://clearstation.com
Screener - http://smallcapcenter.com
Searching Blogs, News, etc. - http://www.icerocket.com/
SEC - http://www.sec.gov
SEC Filings - http://www.edgar-online.com/
SEC Filings - http://www.sec.gov/edgar/searchedgar/companysearch.html
SEC Filings - http://www.secinfo.com
SEC Form Types and Definitions - http://learn.westlawbusiness.com/support/formtypes.html
Secretary of State Sites - All states: http://www.coordinatedlegal.com/SecretaryOfState.html
Seeking Alpha BioTech Stocks - http://www.seekingalpha.com/sector/biotech
Shell Stocks - http://www.shellstockreview.com
SHO Threshold List - http://www.nasdaqtrader.com/Trader.aspx?id=RegSHOThreshold
Short Stocks - http://shortsqueeze.com/
Stock Chart Patterns - www.trending123.com/patterns/index.html
Stock Promotions - www.stockpromoters.com
Stock Promotions - www.stockreads.com/
Stock Research - http://www.stockhouse.com
Stock Scanning - http://bigcharts.marketwatch.com/markets/screener.asp?exchange=118&screen=1&x=15&y=18
Stock Scanning - http://clearstation.etrade.com/cgi-bin/events?Cmd=techev
Stock Scanning - http://markets.usatoday.com/custom/usatoday-com/screener/screener.asp
Stock Scanning - http://screen.yahoo.com/stocks.html
Stock Scanning - http://stockcharts.com/def/servlet/SC.scan
Stock Scanning - http://www.acmechart.com/
Stock Scanning - http://www.americanbulls.com/
Stock Scanning - http://www.barchart.com/
Stock Scanning - http://www.prophet.net/scans/index.jsp
Stock Scanning - http://www.smallcapcenter.com/tools_technicalSearch.asp?page=ANALYTICSSEARCH_IN.ASP
Stock Scanning - http://www.stockciphering.com/index.htm
Stock Scanning - http://www.stockfetcher.com/
Stock Scanning - http://www.stockscores.com/index.asp
Stock Scanning - http://www.stockworm.com/help/tours/stock-screener.html;jsessionid=aEg_MdzO2SH9
Stock Scanning - http://www2.barchart.com/
Technical Analysis - http://stockta.com/
Technical Indicators/Overlays - www.stockcharts.com/school/doku.php
TheStreet.Com - http://www.thestreet.com/
Trading Halts - http://www.nasdaqtrader.com/Trader.aspx?id=TradeHalts
Trading Platform - www.equityfeed.com
Trading Stations - http://www.tradingcomputers.com/index.html
Transfer Agent Contact Information - http://investorshub.advfn.com/boards/board.aspx?board_id=10067
Transfer Agents in the United States - http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Translation Tool - http://www.verbatimsolutions.com/freetranslation.php
USAToday Business - http://markets.usatoday.com/custom/usatoday-com/html-markets.asp
Complete List of Transfer Agents in the United States:
http://www.stocktransfer.com/index.cfm?action=about.network.transferAgents
Stock Market Holiday Schedule
http://www.allstocks.com/html/stock_markets_holidays.html
RULES OF THE BOARD~
*** NO PERSONAL ATTACKS or VULGARITY WILL BE TOLERATED!!!
DISCLAIMER:
Opinions expressed on this board are just opinions. We are not licensed brokers.
Trading strategies discussed on this board are often high risk and are not suitable everyone.
If you consistantly lose money in the market, you may wish to seek the advice of a licensed securities professional.
No one is responsible for your gains or losses in the market except YOU.
Following stocks, strategies discussed on this board, you may LOSE ALL YOUR MONEY.
Please weigh the strategies discussed here carefully against what you are willing to risk.
Please do due diligence before buying or selling ANY SECURITY in the open market; are no guarantees.
TRADE WELL & REMEMBER TO TAKE PROFITS on THE WAY UP!
GOOD LUCK!
*** FOLLOW OUR ALERTS ON TWITTER ***
http://twitter.com/#!/pennystockmomo
*** FOR EARLY ALERTS SIGN UP FOR THE BREAKOUT TRADERS E-MAIL LIST ***
http://investorshub.advfn.com/boards/chairmail_sub.asp?board_id=4929
Posts Today
|
92
|
Posts (Total)
|
2342142
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |